Home/Pipeline/Irinotecan Depot

Irinotecan Depot

Colorectal, Pancreatic, Small‑Cell Lung Cancer

PreclinicalActive

Key Facts

Indication
Colorectal, Pancreatic, Small‑Cell Lung Cancer
Phase
Preclinical
Status
Active
Company

About Nanox Release Technology

Nanox creates nanocarrier formulations to enhance delivery of oncology and infectious disease drugs.

View full company profile